SMCR7L expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.54659643267519E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.64820000000599E-05 |
Normal-vs-Stage2 |
5.60909999999248E-05 |
Normal-vs-Stage3 |
4.55158133405575E-12 |
Normal-vs-Stage4 |
2.21820339874057E-11 |
Stage1-vs-Stage2 |
8.009900E-02 |
Stage1-vs-Stage3 |
1.72523999999452E-05 |
Stage1-vs-Stage4 |
3.58679999999945E-05 |
Stage2-vs-Stage3 |
1.812820E-01 |
Stage2-vs-Stage4 |
1.303750E-01 |
Stage3-vs-Stage4 |
8.001400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.71640529251272E-11 |
Normal-vs-AfricanAmerican |
3.35099999970723E-07 |
Normal-vs-Asian |
6.036100E-02 |
Caucasian-vs-AfricanAmerican |
3.776200E-01 |
Caucasian-vs-Asian |
6.659200E-01 |
AfricanAmerican-vs-Asian |
4.049200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.67261817916187E-12 |
Normal-vs-Female |
8.20390000044746E-07 |
Male-vs-Female |
4.871700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.974700E-04 |
Normal-vs-Age(41-60Yrs) |
3.8945000002677E-08 |
Normal-vs-Age(61-80Yrs) |
8.37070412984531E-11 |
Normal-vs-Age(81-100Yrs) |
1.924250E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.772600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.342200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.523200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.468400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.122400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.219000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.439200E-01 |
Normal-vs-Grade 2 |
1.55379999999816E-06 |
Normal-vs-Grade 3 |
1.04520003763042E-09 |
Normal-vs-Grade 4 |
1.62625468647093E-12 |
Grade 1-vs-Grade 2 |
2.130000E-01 |
Grade 1-vs-Grade 3 |
7.543600E-02 |
Grade 1-vs-Grade 4 |
2.155100E-04 |
Grade 2-vs-Grade 3 |
5.110300E-02 |
Grade 2-vs-Grade 4 |
9.7871000004357E-07 |
Grade 3-vs-Grade 4 |
8.229300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.144800E-03 |
Normal-vs-ccB subtype |
8.88367157614312E-12 |
ccA subtype-vs-ccB subtype |
1.56090000003051E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.1381999787119E-09 |
Normal-vs-N1 |
7.920300E-02 |
N0-vs-N1 |
9.575200E-01 |
|
|